Porcilis Pesti
Adjuvanted vaccine against classical swine fever
Table of contents
Overview
The marketing authorisation for Porcilis Pesti has been withdrawn at the request of the marketing authorisation holder
Authorisation details
| Product details | |
|---|---|
| Name |
Porcilis Pesti
|
| Agency product number |
EMEA/V/C/000046
|
| Active substance |
Classical Swine Fever Virus (CSFV) -E2 subunit antigen
|
| International non-proprietary name (INN) or common name |
Adjuvanted vaccine against classical swine fever
|
| Species |
Pigs
|
| Anatomical therapeutic chemical veterinary (ATCvet) codes |
QI09AD04
|
| Publication details | |
|---|---|
| Marketing-authorisation holder |
Intervet International BV
|
| Revision |
12
|
| Date of issue of marketing authorisation valid throughout the European Union |
09/06/2000
|
| Contact address |
Wim de Körverstraat 35
5831 AN Boxmeer The Netherlands |
Product information
16/09/2011 Porcilis Pesti - EMEA/V/C/000046 - R/0011
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
Immunologicals for suidae
Therapeutic indication
Active immunisation of pigs from the age of 5 weeks onwards to prevent mortality and to reduce clinical signs of Classical Swine Fever, as well as to reduce infection with and excretion of CSF field virus.
The onset of protection is 2 weeks.
The duration of protection is 6 months.